InsiderTrades

Form 4 for WGS GeneDx Holdings Corp.

Accepted 2024-06-04 00:00:00 ET · period of report 2024-06-01 · accession 0001415889-24-015336 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-06-04 2024-06-03 WGS Feeley Kevin CFO S - Sale+OE $20.55 -262 31.3K -0.8% -$5,384
D 2024-06-04 2024-06-01 WGS Feeley Kevin CFO M - OptEx $0.00 +717 31.6K +2% $0
D 2024-06-04 2024-06-01 WGS Feeley Kevin CFO M - OptEx $0.00 -717 6,456 -10% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2024-06-03 S D 262 $20.55 31,291 D — —
2 Common Class A Common Stock 2024-06-01 M A 717 $0.00 31,553 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
3 Derivative Restricted Stock Unit 2024-06-01 M D 717 $0.00 6,456 D — · — to — 717 Class A Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F3) 6.25% vest in quarterly installments over the 4-year period commencing on December 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.